SMITH & NEPHEW ANNOUNCES FDA PANEL HEARING FOR HIP RESURFACING PRODUCT

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces that it has been notified by the US Food and Drug Administration that its Orthopedic and Rehabilitation Devices Panel intends to review the Pre Market Approval Application for the Birmingham Hip Resurfacing implant system on 8 September 2005.

Yahoo News (http://biz.yahoo.com/prnews/050818/nyth096.html?.v=21)